ERBB2 and breast cancer: In fact, some studies have shown that breast cancer metastasis to the brain is increased in triple-negative and in HER-2+ subtypes in addition to cells exhibiting high expression of nestin, promonin-1, CK-5 and WNT/β-catenin signaling [18].